ProPhase Labs board authorizes exploring reverse merger with crypto-focused company and Bitcoin treasury

ProPhase Labs, Inc.

Board unanimously authorized exploring reverse merger with a digital asset-focused operating company (crypto treasury management).
Board approved strategic treasury initiative to acquire and hold digital assets, including Bitcoin, for long-term value.
No binding agreement yet; management will conduct diligence and evaluate shareholder interests.
CEO cites goal to preserve existing asset value: Crown Medical Collections (up to $50M net), Nebula Genomics, BE-Smart test.
Company is a biotech/genomics/consumer products firm considering a pivot into digital assets.

item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.